Emerging evidence suggests that bone-marrow-derived stem and progenitor cells can be used to improve cardiac function after acute myocardial infarction. We tested this concept in the randomized, ...

It is still unclear whether the timing of intracoronary stem cell therapy affects the therapeutic response in patients with reperfused myocardial infarction. The natural course of healing the ...

Rapid reperfusion of the infarct-related coronary artery is of critical importance to salvage ischemic myocardium in acute myocardial infarction (AMI) patients. Unfortunately, myocardial necrosis and ...